Author/Creator: Richardson, Robyn - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Richardson, Robyn

1. A novel non-agonist c-Met antibody drug conjugate with superior potency over a c-Met tyrosine kinase inhibitor in c-Met amplified and non-amplified cancers. Issue 6 (2nd June 2020)

Authors:: Fujita, Ryo; Blot, Vincent; Wong, Eley; Stewart, Christine; Lieuw, Vincent; Richardson, Robyn; Banah, Ammar; Villicana, Jose; Timmer, Anjuli; Coronella, Julia; Newman, Roland; Gymnopoulos, Marco
Journal:: Cancer biology & therapy
Issue:: Volume 21:Issue 6(2020)
Page Start:: 549
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Dolutegravir with tenofovir disoproxil fumarate–emtricitabine as HIV postexposure prophylaxis in gay and bisexual men. (1st June 2017)

Authors:: McAllister, John W.; Towns, Janet M.; Mcnulty, Anna; Pierce, Anna B.; Foster, Rosalind; Richardson, Robyn; Carr, Andrew
Journal:: AIDS
Issue:: Volume 31:Number 9(2017)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Prolonged Effect of Zoledronic Acid on Bone Mineral Density and Turnover in HIV‐Infected Adults on Tenofovir: A Randomized, Open‐Label Study. (24th October 2019)

Authors:: Carr, Andrew; Kerr, Stephen J; Richardson, Robyn; Ebeling, Peter; Pocock, Nicholas; Rojas, Jhon; Martinez, Esteban; Hoy, Jennifer
Journal:: Journal of bone and mineral research
Issue:: Volume 34:Number 12(2019)
Page Start:: 2192
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. Success and failure of initial antiretroviral therapy in adults: an updated systematic review. (1st March 2019)

Authors:: Carr, Andrew; Richardson, Robyn; Liu, Zhixin
Journal:: AIDS
Issue:: Volume 33:Number 3(2019)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. Switch from tenofovir disoproxil fumarate to raltegravir is not associated with weight gain over 96 weeks. (1st April 2020)

Authors:: Carr, Mirella; Richardson, Robyn; Tong, Winnie; Bloch, Mark; Baker, David; Hoy, Jennifer F.
Journal:: AIDS
Issue:: Volume 34:Number 5(2020)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. Zoledronic acid is superior to tenofovir disoproxil fumarate-switching for low bone mineral density in adults with HIV. (10th September 2018)

Authors:: Hoy, Jennifer F.; Richardson, Robyn; Ebeling, Peter R.; Rojas, Jhon; Pocock, Nicholas; Kerr, Stephen J.; Martinez, Esteban; Carr, Andrew
Journal:: AIDS
Issue:: Volume 32:Number 14(2018)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗